Home › NCT06771739

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

Preventing Financial Adversity Among Early-Stage Cancer Patients Through Unrestricted Cash (PAYMENT) Pilot Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Age \>= 18
* Ability to understand English
* Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants
* Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
* Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes)
* Not current Medicaid enrollee
* Not enrolled in hospice
* Screens positive for financial fragility

About the study

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

What is being tested

• Electronic Health Record Review (other)
• Interview (other)
• Support (other)
• Support (other)
• Survey Administration (other)

Sponsor: Fred Hutchinson Cancer Center · Participants: 20 · Started: Oct 1, 2026

Contact the study team

• Ari Bell-Brown · Phone: 206-667-7624

Official record on ClinicalTrials.gov — NCT06771739

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.